Filing Flows › Myomo (MYO) › Q3 2026 › vs Q3 2025
Myomo (MYO) Q3 2026 vs Q3 2025 (year over year)
Myomo's revenue rose $2.2M (+22%) from $10.1M in Q3 2025 to $12.3M in Q3 2026.
Myomo, Q3 2026: revenue $12.3M (+22% year over year), operating margin -14.0%, net loss $4.2M, operating cash flow −$1.3M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $12.3M | $10.1M | $2.2M | +22% |
| Net loss | $4.2M | $3.7M | $570K | +16% |
| Costs & expenses | $16.6M | $13.8M | $2.8M | +20% |
| Operating costs | $14.1M | $13.6M | $446K | +3% |
| Interest & other, net | $2.4M | $10K | $2.4M | 247× |
| Income tax | $104K | $136K | −$32K | -23% |
| Cost of revenue | $3.5M | $3.6M | −$108K | -3% |
| Research & development | $1.8M | $1.5M | $282K | +18% |
| Sales & marketing | $5.1M | $5.3M | −$135K | -3% |
| General & admin | $3.6M | $3.2M | $407K | +13% |
| Operating cash sources | $4.2M | $3.7M | $570K | +16% |
| Depreciation & amortization | $406K | $247K | $159K | +64% |
| Share-based compensation | $1.3M | $584K | $732K | +125% |
| Working capital & other | $1.2M | $1.0M | $201K | +20% |
| Cash used in operations | $1.3M | $1.8M | −$522K | -29% |
| Net loss absorbed | $4.2M | $3.7M | $570K | +16% |
Questions
How much did Myomo's revenue grow year over year in Q3 2026?
Myomo's revenue rose $2.2M (+22%) from $10.1M in Q3 2025 to $12.3M in Q3 2026.